On Oct 22, major Wall Street analysts update their ratings for $Procter & Gamble (PG.US)$, with price targets ranging from $180 to $191.
Morgan Stanley analyst Dara Mohsenian maintains with a buy rating, and adjusts the target price from $174 to $191.
BofA Securities analyst Bryan Spillane maintains with a buy rating, and maintains the target price at $185.
Citi analyst Filippo Falorni maintains with a buy rating.
Evercore analyst Robert Ottenstein maintains with a buy rating, and adjusts the target price from $180 to $183.
TD Cowen analyst Robert Moskow maintains with a buy rating, and maintains the target price at $189.
Furthermore, according to the comprehensive report, the opinions of $Procter & Gamble (PG.US)$'s main analysts recently are as follows:
The prevailing discussion post-Procter & Gamble's first quarter results, which aligned closely with expectations and featured moderate organic sales growth with a slight earnings per share advantage stemming from factors below the profit line, revolves around the sustainable level of the company's organic growth. Highlighting 'solid execution' and anticipating more favorable comparisons, especially in regions such as China and the Middle East, the expectation is for a revival in organic sales growth.
Procter & Gamble is achieving impressive comparable performance in the U.S., Europe, and key markets in Latin America, which collectively account for approximately 85% of its sales and presumably a similar share of profits. Nevertheless, adjustments have been made to the company's Q2 estimates to reflect additional risks associated with the Chinese market, as mentioned by an analyst in a post-earnings discussion.
Here are the latest investment ratings and price targets for $Procter & Gamble (PG.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月22日，多家华尔街大行更新了$宝洁 (PG.US)$的评级，目标价介于180美元至191美元。
摩根士丹利分析师Dara Mohsenian维持买入评级，并将目标价从174美元上调至191美元。
美银证券分析师Bryan Spillane维持买入评级，维持目标价185美元。
花旗分析师Filippo Falorni维持买入评级。
Evercore分析师Robert Ottenstein维持买入评级，并将目标价从180美元上调至183美元。
TD Cowen分析师Robert Moskow维持买入评级，维持目标价189美元。
此外，综合报道，$宝洁 (PG.US)$近期主要分析师观点如下：
关于宝洁公司第一季度结果后的讨论主要集中在公司有望达到期望的特点，特色在于适度的有机销售增长，以及由于利润线以下因素带来的略微每股收益优势，围绕公司有机增长的可持续水平展开。强调"实施稳固"，并预期更有利的比较，尤其是在中国和中东等地区，预计公司有机销售增长将重振。
宝洁公司在美国、欧洲和拉丁美洲等关键市场取得令人瞩目的可比表现，这些市场共占其销售额的约85%，据推测，利润份额大致相同。尽管如此，公司已对第二季度的预估进行了调整，以反映与中国市场相关的额外风险，正如一位分析师在盈利后的讨论中提到的那样。
以下为今日8位分析师对$宝洁 (PG.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
